Baylor University Medical Center, Baylor Charles A Sammons Cancer Center
Baylor University Medical Center, Baylor Charles A Sammons Cancer Center
Dallas, Texas, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Not yet recruiting | Not applicable | 2026-02-12 | NCT07398456 | |
| Tirzepatide Weight Loss for MRD+ Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-02-12 | NCT06517212 | |
| Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Early phase 1 | 2026-02-12 | NCT04265872 | |
| Neratinib in Combination With Ruxolitinib in Patients With mTNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Early phase 1 | 2025-11-10 | NCT06008275 |